Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Binder NK"" wg kryterium: Autor


Wyświetlanie 1-12 z 12
Tytuł:
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth.
Autorzy:
Arman BM; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, Victoria, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Australia.
Binder NK; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, Victoria, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Australia.
de Alwis N; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, Victoria, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Australia.
Beard S; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, Victoria, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Australia.
Debruin DA; Institute for Health and Sport, Victoria University, Melbourne, Victoria, 3000, Australia.; Australian Institute for Musculoskeletal Science, Victoria University, St AlbansVictoria, 3021, Australia.; Department of Medicine-Western Health, Melbourne Medical School, University of Melbourne, St Albans, Victoria, 3021, Australia.
Hayes A; Institute for Health and Sport, Victoria University, Melbourne, Victoria, 3000, Australia.; Australian Institute for Musculoskeletal Science, Victoria University, St AlbansVictoria, 3021, Australia.; Department of Medicine-Western Health, Melbourne Medical School, University of Melbourne, St Albans, Victoria, 3021, Australia.
Tong S; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Australia.
Kaitu'u-Lino TJ; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Australia.
Hannan NJ; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, Victoria, 3084, Australia. .; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Apr 06; Vol. 13 (1), pp. 5646. Date of Electronic Publication: 2023 Apr 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Tocolytic Agents*/pharmacology
Tocolytic Agents*/therapeutic use
Premature Birth*/metabolism
Obstetric Labor, Premature*/drug therapy
Obstetric Labor, Premature*/metabolism
Pregnancy ; Female ; Infant, Newborn ; Mice ; Humans ; Animals ; Nifedipine/metabolism ; Uterine Contraction ; Myometrium/metabolism
Czasopismo naukowe
Tytuł:
Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia.
Autorzy:
Binder NK; Therapeutics Discovery and Vascular Function in Pregnancy Laboratory, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Beard S; Therapeutics Discovery and Vascular Function in Pregnancy Laboratory, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
de Alwis N; Therapeutics Discovery and Vascular Function in Pregnancy Laboratory, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Fato BR; Therapeutics Discovery and Vascular Function in Pregnancy Laboratory, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Nguyen TV; Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Diagnostics Discovery and Reverse Translation Laboratory, Heidelberg, VIC 3084, Australia.
Kaitu'u-Lino TJ; Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Diagnostics Discovery and Reverse Translation Laboratory, Heidelberg, VIC 3084, Australia.
Hannan NJ; Therapeutics Discovery and Vascular Function in Pregnancy Laboratory, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 24; Vol. 24 (7). Date of Electronic Publication: 2023 Mar 24.
Typ publikacji:
Journal Article
MeSH Terms:
Pre-Eclampsia*
Cardiovascular Diseases*
Pregnancy ; Female ; Humans ; Atrial Natriuretic Factor/metabolism ; Endothelial Cells/metabolism ; Endothelium/metabolism
Czasopismo naukowe
Tytuł:
Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries-A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development.
Autorzy:
Fato BR; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
de Alwis N; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Beard S; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Binder NK; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Pritchard N; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Tong S; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Kaitu'u-Lino TJ; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.; Diagnostic Discovery and Reverse Translation in Pregnancy Group, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Hannan NJ; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.; Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 16; Vol. 23 (18). Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Journal Article
MeSH Terms:
Pre-Eclampsia*
Arteries ; Cesarean Section ; Esomeprazole ; Female ; Humans ; Infant, Newborn ; Pregnancy ; Vasoconstriction
Czasopismo naukowe
Tytuł:
Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease.
Autorzy:
de Alwis N; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Fato BR; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Beard S; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Binder NK; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Kaitu'u-Lino TJ; Diagnostics Discovery and Reverse Translation in Pregnancy Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Onda K; Department of Clinical Pharmacology, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
Hannan NJ; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, VIC 3084, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Aug 23; Vol. 23 (17). Date of Electronic Publication: 2022 Aug 23.
Typ publikacji:
Journal Article
MeSH Terms:
Pre-Eclampsia*/metabolism
Biomarkers/metabolism ; Esomeprazole/metabolism ; Esomeprazole/pharmacology ; Esomeprazole/therapeutic use ; Female ; Human Umbilical Vein Endothelial Cells/metabolism ; Humans ; Magnesium Hydroxide ; Placenta/metabolism ; Pregnancy ; Proton Pump Inhibitors/pharmacology ; Proton Pump Inhibitors/therapeutic use ; Vascular Endothelial Growth Factor Receptor-1/metabolism
Czasopismo naukowe
Tytuł:
Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of Preeclampsia.
Autorzy:
de Alwis N; Therapeutics Discovery & Vascular Function Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Binder NK; Therapeutics Discovery & Vascular Function Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Mangwiro YTM; Therapeutics Discovery & Vascular Function Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Beard S; Therapeutics Discovery & Vascular Function Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Pritchard N; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Kadife E; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Obstetrics Diagnostics and Therapeutics Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Fato BR; Therapeutics Discovery & Vascular Function Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Keenan E; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Obstetrics Diagnostics and Therapeutics Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Brownfoot FC; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Obstetrics Diagnostics and Therapeutics Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Kaitu'u-Lino TJ; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Diagnostics Discovery and Reverse Translation in Pregnancy, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Hannan NJ; Therapeutics Discovery & Vascular Function Group, Department of Obstetrics and Gynaecology, The University of Melbourne, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 25; Vol. 23 (15). Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*
Pre-Eclampsia*/metabolism
Acetylcholine ; Animals ; Disease Models, Animal ; Esomeprazole/pharmacology ; Female ; Humans ; Mice ; Mice, Obese ; Nitric Oxide/metabolism ; Nitric Oxide Synthase Type III/metabolism ; Obesity ; Placenta/metabolism ; Pregnancy
Czasopismo naukowe
Tytuł:
NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast.
Autorzy:
de Alwis N; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Beard S; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Binder NK; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Pritchard N; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Kaitu'u-Lino TJ; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Walker SP; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Stock O; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Groom KM; Liggins Institute, University of Auckland, Auckland, 1023, New Zealand.
Petersen S; Centre for Maternal Fetal Medicine, Mater Mothers' Hospital, South Brisbane, QLD, 4101, Australia.
Henry A; School of Women's and Children's Health, UNSW Medicine, University of New South Wales, Sydney, Australia.
Said JM; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.; Maternal Fetal Medicine, Joan Kirner Women's and Children's Sunshine Hospital, St Albans, VIC, 3021, Australia.
Seeho S; Northern Clinical School, Women and Babies Research, The University of Sydney, St Leonards, NSW, 2065, Australia.
Kane SC; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.; Department of Maternal Fetal Medicine, Royal Women's Hospital, Parkville, VIC, 3052, Australia.
Tong S; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia.
Hannan NJ; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia. .; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia. .; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia. .; Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC, 3084, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Oct 19; Vol. 11 (1), pp. 20670. Date of Electronic Publication: 2021 Oct 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fetal Growth Retardation/*metabolism
Nuclear Receptor Subfamily 4, Group A, Member 2/*metabolism
Placenta/*metabolism
Placenta Growth Factor/*metabolism
Pre-Eclampsia/*metabolism
Trophoblasts/*metabolism
Adult ; Antioxidants/metabolism ; Female ; Humans ; Hypoxia/metabolism ; Inflammation/metabolism ; Male ; Oxidative Stress/physiology ; Placenta Diseases/metabolism ; Pregnancy ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł:
Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia.
Autorzy:
Binder NK; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg 3084, Australia.
MacDonald TM; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg 3084, Australia.
Beard SA; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg 3084, Australia.
de Alwis N; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg 3084, Australia.
Tong S; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg 3084, Australia.
Kaitu'u-Lino TJ; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg 3084, Australia.; Diagnostics Discovery and Reverse Translation, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.
Hannan NJ; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Therapeutics Discovery and Vascular Function Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg 3084, Australia.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 Jul 30; Vol. 10 (15). Date of Electronic Publication: 2021 Jul 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia.
Autorzy:
de Alwis N; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Northern Health, Epping, VIC, 3076, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Beard S; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Northern Health, Epping, VIC, 3076, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Binder NK; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Pritchard N; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Kaitu'u-Lino TJ; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Walker SP; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Stock O; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Groom K; Liggins Institute, University of Auckland, Auckland, 1023, New Zealand.
Petersen S; Centre for Maternal Fetal Medicine, Mater Mothers' Hospital, South Brisbane, QLD, 4101, Australia.
Henry A; School of Women's and Children's Health, UNSW Medicine, University of New South Wales, Sydney, Australia.
Said JM; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.; Maternal Fetal Medicine, Joan Kirner Women's & Children's Sunshine Hospital, St Albans, VIC, 3021, Australia.
Seeho S; The University of Sydney Northern Clinical School, Women and Babies Research, St Leonards, NSW, 2065, Australia.
Kane SC; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.; Department of Maternal Fetal Medicine, Royal Women's Hospital, Parkville, VIC, 3052, Australia.
Hui L; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Northern Health, Epping, VIC, 3076, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Tong S; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
Hannan NJ; Therapeutics Discovery and Vascular Function in Pregnancy Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia. .; Translational Obstetrics Group, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia. .; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, 3084, Australia. .; Northern Health, Epping, VIC, 3076, Australia. .; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 10; Vol. 11 (1), pp. 5540. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation*
Fetal Growth Retardation/*metabolism
Hypoxia/*metabolism
Microfilament Proteins/*biosynthesis
Placenta/*metabolism
RNA, Messenger/*biosynthesis
rho GTP-Binding Proteins/*biosynthesis
Adult ; Female ; Humans ; Placenta/blood supply ; Pregnancy
Czasopismo naukowe
Tytuł:
Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
Autorzy:
Hannan NJ; Translational Obstetrics Group, Mercy Perinatal, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Binder NK; Translational Obstetrics Group, Mercy Perinatal, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Beard S; Translational Obstetrics Group, Mercy Perinatal, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Nguyen TV; Translational Obstetrics Group, Mercy Perinatal, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Kaitu'u-Lino TJ; Translational Obstetrics Group, Mercy Perinatal, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Tong S; Translational Obstetrics Group, Mercy Perinatal, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Apr 11; Vol. 13 (4), pp. e0187082. Date of Electronic Publication: 2018 Apr 11 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antioxidants/*metabolism
Melatonin/*pharmacology
Placenta/*metabolism
Pre-Eclampsia/*drug therapy
Trophoblasts/*metabolism
Vascular Endothelial Growth Factor Receptor-1/*metabolism
Female ; Gene Expression Regulation/drug effects ; Humans ; Melatonin/therapeutic use ; Placenta/drug effects ; Pre-Eclampsia/pathology ; Pregnancy ; Solubility ; Trophoblasts/drug effects ; Tumor Necrosis Factor-alpha/pharmacology ; Vascular Endothelial Growth Factor Receptor-1/chemistry
Czasopismo naukowe
Tytuł:
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
Autorzy:
Kaitu'u-Lino TJ; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Brownfoot FC; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Beard S; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Cannon P; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Hastie R; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Nguyen TV; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Binder NK; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Tong S; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Hannan NJ; Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Feb 21; Vol. 13 (2), pp. e0188845. Date of Electronic Publication: 2018 Feb 21 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Endothelium, Vascular/*drug effects
Esomeprazole/*administration & dosage
Metformin/*administration & dosage
Pre-Eclampsia/*drug therapy
Vascular Endothelial Growth Factor Receptor-1/*metabolism
Endothelium, Vascular/physiopathology ; Female ; Human Umbilical Vein Endothelial Cells ; Humans ; Pregnancy
Czasopismo naukowe
Tytuł:
Placental Growth Factor Is Secreted by the Human Endometrium and Has Potential Important Functions during Embryo Development and Implantation.
Autorzy:
Binder NK; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, 3084, Australia.; School of BioSciences, University of Melbourne, Parkville, 3010, Australia.
Evans J; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, 3168, Australia.; Department of Physiology, Monash University, Clayton, 3168, Australia.
Salamonsen LA; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, 3168, Australia.; Department of Obstetrics and Gynecology, Monash University, Clayton, 3168, Australia.
Gardner DK; School of BioSciences, University of Melbourne, Parkville, 3010, Australia.
Kaitu'u-Lino TJ; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, 3084, Australia.
Hannan NJ; Translational Obstetrics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, 3084, Australia.; School of BioSciences, University of Melbourne, Parkville, 3010, Australia.; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, 3168, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Oct 06; Vol. 11 (10), pp. e0163096. Date of Electronic Publication: 2016 Oct 06 (Print Publication: 2016).
Typ publikacji:
Journal Article
MeSH Terms:
Embryo Implantation*
Endometrium/*metabolism
Placenta Growth Factor/*metabolism
Animals ; Blastocyst/cytology ; Blastocyst/drug effects ; Blastocyst/physiology ; Cell Adhesion/drug effects ; Cell Count ; Endometrium/cytology ; Epithelial Cells/cytology ; Epithelial Cells/drug effects ; Female ; Humans ; Mice ; Placenta Growth Factor/pharmacology ; Protein Transport ; Uterus/metabolism
Czasopismo naukowe
Tytuł:
Paternal diet-induced obesity retards early mouse embryo development, mitochondrial activity and pregnancy health.
Autorzy:
Binder NK; Department of Zoology, University of Melbourne, Parkville, Victoria, Australia.
Hannan NJ
Gardner DK
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (12), pp. e52304. Date of Electronic Publication: 2012 Dec 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fathers*
Health*
Diet, High-Fat/*adverse effects
Embryo, Mammalian/*cytology
Embryo, Mammalian/*embryology
Mitochondria/*metabolism
Obesity/*physiopathology
Adipose Tissue/metabolism ; Animals ; Blastocyst/cytology ; Cell Lineage ; Female ; Fertilization in Vitro ; Fetal Viability ; Kinetics ; Male ; Membrane Potential, Mitochondrial ; Mice ; Mice, Inbred C57BL ; Obesity/etiology ; Obesity/pathology ; Pregnancy ; Pregnancy Rate ; Spermatozoa/physiology ; Weight Gain
Czasopismo naukowe
    Wyświetlanie 1-12 z 12

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies